The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Atorvastatin Rowa 20 mg film-coated tablets.

20 milligram(s) Film-coated tablet

Rowa Pharmaceuticals LimitedPA0074/079/002

Main Information

Trade NameAtorvastatin Rowa 20 mg film-coated tablets.
Active SubstancesAtorvastatin calcium trihydrate
Strength20 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderRowa Pharmaceuticals Limited
Licence NumberPA0074/079/002

Group Information

ATC CodeC10AA HMG CoA reductase inhibitors
C10AA05 atorvastatin


Licence Issued22/11/2019
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version

Generics Information

Interchangeable List CodeIC0001-003-003
Interchangeable List DocumentPDF of Interchangeable List
« Back